This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect 2020; 26: 579-5. 83. doi: 10.1016/j.cmi.2019.09.006MaverPJPoljakMPrimary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans20202657958310.1016/j.cmi.2019.09.00631539637Open DOISearch in Google Scholar
Killeen JL, Dye T, Grace C, Hiraoka M. Improved abnormal Pap smear triage using cervical cancer biomarkers. J Low Genit Tract Dis 2014; 18: 1-7. doi: 10.1097/LGT.0b013e31828aeb39KilleenJLDyeTGraceCHiraokaMImproved abnormal Pap smear triage using cervical cancer biomarkers2014181710.1097/LGT.0b013e31828aeb3923760145Open DOISearch in Google Scholar
Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z. Performance of p16/Ki-67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS. BMC Cancer 2019; 19: 271. doi: 10.1186/s12885-019-5492-9ZhuYRenCYangLZhangXLiuLWangZPerformance of p16/Ki-67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS20191927110.1186/s12885-019-5492-9643795930917784Open DOISearch in Google Scholar
Sawaya GF, Smith-McCune K, Kuppermann M. Cervical cancer screening: more choices in 2019. JAMA 2019; 321: 2018-9. doi: 10.1001/jama.2019.4595SawayaGFSmith-McCuneKKuppermannMCervical cancer screening: more choices in 201920193212018910.1001/jama.2019.4595665635831135834Open DOISearch in Google Scholar
White CM, Bakhiet S, Bates M, Ruttle C, Pilkington LJ, Keegan H, et al. CERVIVA consortium. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study. Cancer Epidemiol 2020; 68: 101793. doi: 10.1016/j.canep.2020.101793WhiteCMBakhietSBatesMRuttleCPilkingtonLJKeeganHet alCERVIVA consortium20206810179310.1016/j.canep.2020.10179332841926Open DOISearch in Google Scholar
Gavrić Lovrec V, Erlah T, Dobnik S, Takač I. The influence of smoking on the frequency and characteristics of complications following large loop excision of the transformation zone (LLETZ). Acta medico-biotechnica 2019; 1: 40-6.GavrićLovrec VErlahTDobnikSTakačIThe influence of smoking on the frequency and characteristics of complications following large loop excision of the transformation zone (LLETZ)20191406Search in Google Scholar
Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012; 30(Suppl): F88-99. doi: 10.1016/j.vaccine.2012.06.095. Erratum in: Vaccine 2013; 31: 6266. doi: 10.1016/j.vaccine.2012.06.095ArbynMRoncoGAnttilaAMeijerCJPoljakMOgilvieGet alEvidence regarding human papillomavirus testing in secondary prevention of cervical cancer201230SupplF889910.1016/j.vaccine.2012.06.095Erratum in: Vaccine 2013; 31: 626610.1016/j.vaccine.2012.06.09523199969Open DOISearch in Google Scholar
Petry KU, Schmidt D, Scherbring S, Luyten A, Reinecke-Lüthge A, Bergeron C, et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology. Gynecol Oncol 2011; 121: 5059. doi: 10.1016/j.ygyno.2011.02.033PetryKUSchmidtDScherbringSLuytenAReinecke-LüthgeABergeronCet alTriaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology2011121505910.1016/j.ygyno.2011.02.03321420158Open DOISearch in Google Scholar
Wright TC Jr, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, et al. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial. Gynecol Oncol 2017; 144: 51-6. doi: 10.1016/j.ygynoWrightTC JrBehrensCMRanger-MooreJRehmSSharmaAStolerMHet alTriaging HPV-positive women with p16/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial201714451610.1016/j.ygynoOpen DOISearch in Google Scholar
Schmidt D, Bergeron C, Denton KJ, Ridder R; European CINtec Cytology Study Group. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol 2011; 119: 158-66. doi: 10.1002/cncy.20140SchmidtDBergeronCDentonKJRidderREuropean CINtec Cytology Study Group p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study20111191586610.1002/cncy.2014021442767Open DOISearch in Google Scholar
Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, et al. PALMS Study Group. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Cancer Cytopathol 2015; 123: 373-81. doi: 10.1002/cncy.21542BergeronCIkenbergHSideriMDentonKBogersJSchmidtDet alPALMS Study Group20151233738110.1002/cncy.2154225891096Open DOISearch in Google Scholar
Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, et al.; PALMS Study Group. Screening for cervical cancer precursors with p16/ Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst 2013; 105: 1550-7. doi: 10.1093/jnci/djt235IkenbergHBergeronCSchmidtDGriesserHAlamedaFAngeloniCet alPALMS Study Group. Screening for cervical cancer precursors with p16/ Ki-67 dual-stained cytology: results of the PALMS study20131051550710.1093/jnci/djt235Open DOISearch in Google Scholar
Tjalma WAA. Diagnostic performance of dual-staining cytology for cervical cancer screening: a systematic literature review. Eur J Obstet Gynecol Reprod Biol 2017; 210: 275-80. doi: 10.1016/j.ejogrbTjalmaWAADiagnostic performance of dual-staining cytology for cervical cancer screening: a systematic literature review20172102758010.1016/j.ejogrbOpen DOISearch in Google Scholar
Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci US A 1996; 93: 4350-4. doi: 10.1073/pnas.93.9.4350KhleifSNDeGregoriJYeeCLOttersonGAKayeFJNevinsJRet alInhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity1996934350410.1073/pnas.93.9.4350Open DOISearch in Google Scholar
Wentzensen N, von Knebel Doeberitz M. Biomarkers in cervical cancer screening. Dis Markers 2007; 23: 315-30. doi: 10.1155/2007/678793. doi: 10.1155/2007/678793WentzensenNvonKnebel Doeberitz MBiomarkers in cervical cancer screening2007233153010.1155/2007/67879310.1155/2007/678793Open DOISearch in Google Scholar
Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-8. doi: 10.1016/S0002-9440(10)65689-1SanoTOyamaTKashiwabaraKFukudaTNakajimaTExpression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions19981531741810.1016/S0002-9440(10)65689-1Open DOISearch in Google Scholar
Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-84. doi: 10.1002/ijc.1174KlaesRFriedrichTSpitkovskyDRidderRRudyWPetryUet alOverexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri2001922768410.1002/ijc.117411291057Open DOISearch in Google Scholar
Wang HR, Li YC, Guo HQ, Yu LL, Wu Z, Yin J, et al. A cocktail of p16INK4a and Ki-67, p16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening. Oncotarget 2017; 8: 83890-9. doi: 10.18632/oncotarget.19870WangHRLiYCGuoHQYuLLWuZYinJet alA cocktail of p16INK4a and Ki-67, p16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening2017883890910.18632/oncotarget.19870566356229137390Open DOISearch in Google Scholar
Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993; 123: 513-22. doi: 10.1083/jcb.123.3.513SchlüterCDuchrowMWohlenbergCBeckerMHKeyGFladHDet alThe cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins19931235132210.1083/jcb.123.3.51322001298227122Open DOISearch in Google Scholar
Yu L, Fei L, Liu X, Pi X, Wang L, Chen S. Application of p16/Ki-67 dual-staining cytology in cervical cancers. J Cancer 2019; 10: 2654-60. doi: 10.7150/jca.32743YuLFeiLLiuXPiXWangLChenSApplication of p16/Ki-67 dual-staining cytology in cervical cancers20191026546010.7150/jca.32743658492531258773Open DOISearch in Google Scholar
Ivanus U, Jerman T, Fokter Repse A, Takac I, Prevodnik VK, Marcec M, et al. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiol Oncol 2018; 52: 399-412. doi: 10.2478/raon-2018-0036IvanusUJermanTFokterRepse ATakacIPrevodnikVKMarcecMet alRandomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches20185239941210.2478/raon-2018-0036628718330216191Open DOISearch in Google Scholar
Kloboves Prevodnik V, Jerman T, Nolde N, Repše Fokter A, Jezeršek S, Pohar Marinšek Ž, et al. Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears. Diagn Pathol 2019; 1: 48. doi: 10.1186/s13000-019-0821-5KlobovesPrevodnik VJermanTNoldeNRepšeFokter AJezeršekSPoharMarinšek Žet alInterobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears201914810.1186/s13000-019-0821-5653369731122253Open DOISearch in Google Scholar
Prevodnik VK, Marinsek ZP, Zalar J, Rozina H, Kotnik N, Jerman T, et al. Evaluation of the training program for p16/Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry. Radiol Oncol 2020; 2: 201-8. doi: 10.2478/raon-2020-0018PrevodnikVKMarinsekZPZalarJRozinaHKotnikNJermanTet alEvaluation of the training program for p16/Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry20202201810.2478/raon-2020-0018727664632229681Open DOISearch in Google Scholar
Guidelines for management of women with cervical precancerous lesions. Ursic-Vrscaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger I, et al, editors. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana; 2011. [Accessed 2021 Feb 5]. Available at: https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/2011_Smernice_web.pdfLjubljanaInstitute of Oncology Ljubljana;2011[Accessed 2021 Feb 5]. Available athttps://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/2011_Smernice_web.pdfSearch in Google Scholar
Waldstrøm M, Christensen RK, Ørnskov D. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. Cancer Cytopathol 2013; 121: 136-45. doi: 10.1002/cncy.21233WaldstrømMChristensenRKØrnskovDEvaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion20131211364510.1002/cncy.2123322987560Open DOISearch in Google Scholar
Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold M A, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res 2012; 18: 4154-62. doi: 10.1158/1078-0432.CCR-12-0270WentzensenNSchwartzLZunaRESmithKMathewsCGoldM Aet alPerformance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population20121841546210.1158/1078-0432.CCR-12-0270423761222675168Open DOISearch in Google Scholar
Šekoranja D, Repše Fokter A. Triaging atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion with p16/Ki-67 dual stain. J Low Genit Tract Dis 2017; 21: 108-11. doi: 10.1097/LGT.0000000000000297ŠekoranjaDRepšeFokter ATriaging atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion with p16/Ki-67 dual stain2017211081110.1097/LGT.000000000000029728244884Open DOISearch in Google Scholar
Peeters E, Wentzensen N, Bergeron C, Arbyn M. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology. Cancer Cytopathol 2019; 127: 169-80. doi: 10.1002/cncy.22103PeetersEWentzensenNBergeronCArbynMMeta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology20191271698010.1002/cncy.2210330811902Open DOISearch in Google Scholar
Edgerton N, Cohen C, Siddiqui MT. Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations. Diagn Cytopathol 2013; 41: 35-40. doi: 10.1002/dc.21757EdgertonNCohenCSiddiquiMTEvaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations201341354010.1002/dc.2175721710645Open DOISearch in Google Scholar
Dovnik A, Repše Fokter A. p16/Ki-67 Immunostaining in the triage of post-menopausal women with low-grade cytology results. J Low Genit Tract Dis 2020; 24: 235-7. doi: 10.1097/LGT.0000000000000539DovnikARepšeFokter Ap16/Ki-67 Immunostaining in the triage of post-menopausal women with low-grade cytology results202024235710.1097/LGT.000000000000053932574476Open DOISearch in Google Scholar
Dovnik A, Repše-Fokter A. p16/Ki-67 immunostaining in the triage of young women with LSIL, ASC-US, and ASC-H cytology. Diagn Cytopathol 2020; 48: 96-7. doi: 10.1002/dc.24339DovnikARepše-FokterAp16/Ki-67 immunostaining in the triage of young women with LSIL, ASC-US, and ASC-H cytology20204896710.1002/dc.2433931714671Open DOISearch in Google Scholar
Frega A, Pavone M, Sesti F, Leone C, Bianchi P, Cozza G, et al. Sensitivity and specificity values of high-risk HPV DNA, p16/Ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Eur Rev Med Pharmacol Sci 2019; 24: 10672-7. doi: 10.26355/eurrev-201912-19765FregaAPavoneMSestiFLeoneCBianchiPCozzaGet alSensitivity and specificity values of high-risk HPV DNA, p16/Ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL)20192410672710.26355/eurrev-201912-19765Open DOISearch in Google Scholar
Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, et al. Clinical evaluation of human papillomavirus screening with p16/Ki-67 dual stain tri-age in a large organized cervical cancer screening program. JAMA Intern Med 2019; 179: 881-8. doi: 10.1001/jamainternmed.2019.0306WentzensenNClarkeMABremerRPoitrasNTokugawaDGoldhoffPEet alClinical evaluation of human papillomavirus screening with p16/Ki-67 dual stain tri-age in a large organized cervical cancer screening program2019179881810.1001/jamainternmed.2019.0306651557231081870Open DOISearch in Google Scholar
Stoler MH, Baker E, Boyle S, Aslam S, Ridder R, Huh WK, et al. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA. Jr. Int J Cancer 2020; 146: 599-607. doi: 10.1002/ijc.32669StolerMHBakerEBoyleSAslamSRidderRHuhWKet alApproaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA202014659960710.1002/ijc.32669707893931490545Open DOISearch in Google Scholar
Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, et al. the New Technology for Cervical Cancer 2 Working Group. p16/Ki-67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women. J Natl Cancer Inst. 2021; 3: 292-300. doi: 10.1093/jnci/djaa105GiorgiRossi PCarozziFRoncoGAlliaEBisanziSGillio-TosAet althe New Technology for Cervical Cancer 2 Working Group2021329230010.1093/jnci/djaa105793605432745170Open DOISearch in Google Scholar
Han Q, Guo H, Geng L, Wang Y. p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening. Chin J Cancer Res 2020; 2: 208-17. doi: 10.21147/j.issn.1000-9604.2020.02.08HanQGuoHGengLWangYp16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening202022081710.21147/j.issn.1000-9604.2020.02.08721909532410798Open DOISearch in Google Scholar
Luttmer R, Dijkstra MG, Snijders PJF, Berkhof J, van Kemenade FJ, Rozendaal L, et al. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population. Mod Pathol 2016; 29: 870-8. doi: 10.1038/modpathol.2016.80LuttmerRDijkstraMGSnijdersPJFBerkhofJvan KemenadeFJRozendaalLet alp16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population201629870810.1038/modpathol.2016.8027150161Open DOISearch in Google Scholar
Ziemke P. p16/Ki-67 Immunocytochemistry in gynecological cytology: limitations in practice. Acta Cytologica 2017; 61: 230-6. doi: 10.1159/000475979ZiemkePp16/Ki-67 Immunocytochemistry in gynecological cytology: limitations in practice201761230610.1159/00047597928521315Open DOISearch in Google Scholar
Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, et al. Five-year risk of cervical precancer following p16/Ki-67 dual-stain triage of HPV-positive women. JAMA Oncol 2019; 5: 181-6. doi:10.1001/jamaoncol.2018.4270ClarkeMACheungLCCastlePESchiffmanMTokugawaDPoitrasNet alFive-year risk of cervical precancer following p16/Ki-67 dual-stain triage of HPV-positive women20195181610.1001/jamaoncol.2018.4270643955630325982Open DOISearch in Google Scholar
Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, et al. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. J Cancer 2015; 136: 2361-8. doi: 10.1002/ijc.29290UijterwaalMHPolmanNJWitteBIvan KemenadeFJRijkaartDBerkhofJet alTriaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data20151362361810.1002/ijc.2929025345358Open DOISearch in Google Scholar